PIK3CA and neoplasm: DNA extracted from each tumor pair was used to determine PIK3CA and AKT1 mutation status with a sensitive and specific qPCR-based assay [11], and serial sections from each tumor pair were also used to assess Ki67 staining and total PTEN loss via IHC (Table 1).